Call for Papers: Cancer Immunotherapy and Vaccines

Cancer

BMC Immunology is currently accepting manuscripts to the new thematic series “Cancer Immunotherapy and Vaccines”.

The purpose of this thematic series is to bring together the latest advances in both biological and computational research, looking broadly at the basic biological aspects of immunotherapy, emerging immunotherapies (both prophylactic and preventive) and different vaccination approaches.

Read More

Featured article: Fighting cancer with the immune system

Pixabay

Studies have shown the immune system has the potential to remove tumor cells in a patient’s body. This article describes a method for generating antitumor  cytotoxic T lymphocytes (CTLs)  specific for the epitopes of the HER2/neu tumor-associated antigen. These CTLs are then shown to have a pronounced cytotoxic effect on tumor cells expressing the HER2/neu marker.

Read More

Articles

View all articles

View all articles

Aims and scope

BMC Immunology is an open access journal publishing original peer-reviewed research articles in molecular, cellular, tissue-level, organismal, functional, and developmental aspects of the immune system as well as clinical studies and animal models of human diseases.

Editor

Section Editors

  • Simon R Carding, University of East Anglia
  • Lucienne Chatenoud, Hospital Necker
  • Olivier Garraud, Institut National de la Transfusion Sanguine
  • James Li, University of Hong Kong
  • J Philip McCoy, National Institutes of Health
  • Wayne Thomas, Institute for Child Health Research

Data Support Services pilot

Authors submitting to this journal can opt to use a new service that will make it easier to share research data.

Find out more

Tweets

Advertisement